Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic MedicinesAccesswire • 03/23/23
Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic MedicinesGlobeNewsWire • 03/21/23
Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewsWire • 02/23/23
Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/23
Can Generation Bio Co. (GBIO) Climb 184% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 12/05/22
Wall Street Analysts Think Generation Bio Co. (GBIO) Could Surge 176%: Read This Before Placing a BetZacks Investment Research • 11/17/22
Generation Bio Reports Business Highlights and Third Quarter 2022 Financial ResultsGlobeNewsWire • 11/03/22
Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine SummitGlobeNewsWire • 09/22/22
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial ResultsGlobeNewsWire • 08/04/22
Wall Street Analysts See a 174% Upside in Generation Bio Co. (GBIO): Can the Stock Really Move This High?Zacks Investment Research • 07/11/22
Generation Bio Co. (GBIO) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/06/22
Generation Bio Reports Business Highlights and First Quarter 2022 Financial ResultsGlobeNewsWire • 05/05/22
Generation Bio to Participate in 21st Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/05/22
How Much Upside is Left in Generation Bio Co. (GBIO)? Wall Street Analysts Think 505%Zacks Investment Research • 03/25/22
Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 02/24/22
Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating OfficerGlobeNewsWire • 02/10/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Generation Bio Co. - GBIOPRNewsWire • 01/06/22